Brand Name: Hepcvel
Generic Name: Sofosbuvir and Velpatasvir
Strength: 100 mg Velpatasvir and
400 mg Sofosbuvir
Manufactured by: Cipla Ltd
Packing: One Bottle Pack of 28 tablets


Hepcvel Tablets:

“HEPCVEL” (Sofosbuvir 400 mg and Velpatasvir 100 mg) this mix is used to treat the infection of chronic viral hepatitis C (HCV) of all six genotypes: 1, 2, 3, 4, 5, 6. Sofosbuvir and Velpatasvir is an effective formula of two active substances against the hepatitis C virus. This panthenotypic scheme reduces the amount of hepatitis C virus in the body by preventing its replication in the blood and tissues.

General information for medicine identification:

1.1. Trade (proprietary) name of the medicine: Hepcvel

1.2. International (non-proprietary) name: sofosbuvir and velpatasvir.

1.3. Dosage form and destination: film-coated tablets, for oral administration.

1.4. Composition:

Active substances: active substances Hepcvel are sofosbuvir and velpatasvir. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.

1.5. Pharmacotherapeutic group: antiviral.

Indications for use:

Hepcvel combined medicine with a fixed dose of sofosbuvir, nucleotide analog inhibiting the polymerase NS5B of HCV, and velpatasvir, a new inhibitor of NS5A. The medicine is intended for the treatment of chronic hepatitis C genotypes 1, 2, 3, 4, 5 and 6 in patients older than 18 years

  • Without cirrhosis of the liver or with compensated cirrhosis of the liver;
  • With decompensate liver cirrhosis with the combined use of ribavirin.


Do not take the medicine and tell the doctor immediately if; you have the allergy to Sofosbuvir and Velpatasvir or any other component of the medicine. A combined treatment regimen using velpatasvir, sofosbuvir and ribavirin contraindicated in patients who have contraindications to ribavirin.

Side Effects

Hepcvel Side effects are mild and occur in no more than 20% of patients. Of the most common can be:

A headache;






There are no reviews yet.

Be the first to review “Hepcvel”

Your email address will not be published. Required fields are marked *